• Johnson & Johnson announces a $5.5 billion settlement over talc-related lawsuits.
• The settlement addresses approximately 69,000 cases alleging ovarian cancer links.
• J&J maintains that its talc products are safe and does not contain asbestos.
• The deal must be approved by a judge and covers only existing claims.
• The UK has a separate ongoing case related to talc litigation against J&J.

Johnson & Johnson (J&J) has agreed to a historic settlement of $5.5 billion to resolve tens of thousands of lawsuits claiming that its talc-based baby powder caused ovarian cancer. This settlement is intended to conclude a prolonged legal battle that has significantly impacted the company for years, addressing around 69,000 cases consolidated in federal and state courts, equating to 99.75% of all remaining talc claims, according to Reuters and Channel News Asia.

Erik Haas, J&J's vice president of litigation, stated, "While we are confident the company would have ultimately prevailed with further litigation... this resolution allows the company to put this matter behind it." J&J has consistently maintained that the claims are “meritless” and emphasized the safety of its talc products, which it stated do not contain asbestos, as reported by Al Jazeera and BBC.

Despite these affirmations, the company faced a notable court victory recently when a judge expressed doubt regarding individual plaintiffs' ability to establish a direct link between talc and ovarian cancer. This ongoing litigation had resumed in March 2025 after a significant hiatus that followed J&J's initial attempts at resolving claims through a bankruptcy process, as indicated by Reuters.

The settlement agreement specifically pertains only to existing claims in the United States and does not encompass future lawsuits or the considerable ongoing litigation in the UK against J&J, which alleges that the company knowingly continued to sell potentially harmful talc products, according to Channel News Asia and BBC.